Trial · NCT02594124
Results by group1,465
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 1,465
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs) | Infantile SMA Onset CS3A | AEs | 13 | Participants | |
| Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs) | Infantile SMA Onset CS3B Previous Control | AEs | 24 | Participants | |
| Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs) | Infantile SMA Onset CS3B Previous ISIS 396443 | AEs | 65 | Participants | |
| Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs) | Infantile SMA Onset 232SM202 | AEs | 12 | Participants | |
| Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs) | Later SMA Onset CS12 Type 2 | AEs | 20 | Participants | |
| Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs) | Later SMA Onset CS12 Type 3 | AEs | 25 | Participants | |
| Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs) | Later SMA Onset CS4 Previous Control | AEs | 42 | Participants | |
| Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs) | Later SMA Onset CS4 Previous ISIS 396443 | AEs | 80 | Participants | |
| Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs) | Later SMA Onset 232SM202 | AEs | 8 | Participants | |
| Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs) | Infantile SMA Onset CS3A | SAEs | 11 | Participants | |
| Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs) | Infantile SMA Onset CS3B Previous Control | SAEs | 23 | Participants | |
| Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs) | Infantile SMA Onset CS3B Previous ISIS 396443 | SAEs | 59 | Participants | |
| Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs) | Infantile SMA Onset 232SM202 | SAEs | 9 | Participants | |
| Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs) | Later SMA Onset CS12 Type 2 | SAEs | 12 | Participants | |
| Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs) | Later SMA Onset CS12 Type 3 | SAEs | 6 | Participants | |
| Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs) | Later SMA Onset CS4 Previous Control | SAEs | 26 | Participants | |
| Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs) | Later SMA Onset CS4 Previous ISIS 396443 | SAEs | 47 | Participants | |
| Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs) | Later SMA Onset 232SM202 | SAEs | 5 | Participants | |
| Number of Participants With Vital Sign Abnormalities Reported as AEs | Infantile SMA Onset CS3A | Bradycardia | 1 | Participants | |
| Number of Participants With Vital Sign Abnormalities Reported as AEs | Infantile SMA Onset CS3B Previous Control | Bradycardia | 0 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02594124/results